TLR9 and cancer: Ex vivo studies in MC38 colon cancer cell lines and hepatic metastasis models demonstrated that NETs promote release of high-mobility group box 1 (HMGB1), which activates Toll-like receptor 9 (TLR9) signalling in cancer cells.